August 25, 2023 August 25, 2023Categories Trial ResultsTrial Results: ECOG-ACRIN Research Round-UpSummaries of recently published ECOG-ACRIN research results
October 13, 2022 October 13, 2022Categories From the Co-ChairsFrom the Co-Chairs, October 2022Research results in breast and kidney cancer; recognition of key colleagues; and a sneak peek of the Fall 2022 Group Meeting
October 13, 2022 October 13, 2022Categories Trial ResultsTrial Results: ECOG-ACRIN Completes the First Randomized Phase 3 Clinical Trial of Neoadjuvant Immunotherapy in Patients with Kidney CancerThe phase III PROSPER RCC clinical trial demonstrated that priming the immune system with nivolumab before surgery, then continuing nivolumab, did not improve recurrence-free survival in patients with high-risk renal cell carcinoma